Biologics Versus JAK Inhibitors. Part II: Risk of Infections. A Narrative Review.

MLA

Mansilla-Polo, Miguel, and Daniel Morgado-Carrasco. “Biologics Versus JAK Inhibitors. Part II: Risk of Infections. A Narrative Review.” Dermatology & Therapy, vol. 14, no. 8, Aug. 2024, pp. 1983–2038. EBSCOhost, https://doi.org/10.1007/s13555-024-01203-2.

APA

Mansilla-Polo, M., & Morgado-Carrasco, D. (2024). Biologics Versus JAK Inhibitors. Part II: Risk of Infections. A Narrative Review. Dermatology & Therapy, 14(8), 1983–2038. https://doi.org/10.1007/s13555-024-01203-2

Chicago

Mansilla-Polo, Miguel, and Daniel Morgado-Carrasco. 2024. “Biologics Versus JAK Inhibitors. Part II: Risk of Infections. A Narrative Review.” Dermatology & Therapy 14 (8): 1983–2038. doi:10.1007/s13555-024-01203-2.